Patents by Inventor Henry V. Roohk

Henry V. Roohk has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method and apparatus for extracorporeal blood treatment
    Patent number: 5104373
    Abstract: Disclosed is a multimodal method and apparatus for extracorporeally treating certain blood borne infections, such as the infection of T-lymphocytes with the Human Immunodeficiency Virus. The method and apparatus of the invention includes (a) hyperthermic, (b) mechanical shear inducing, and (c) irradiation treatment modalities. These three treatment modalities may be carried out separately, in any order, or simultaneously, in any combination. The irradiation treatment mode preferably includes methods and means for subjecting at least a fraction of the blood to ultraviolet and/or x-ray and/or laser radiation. Before the blood is withdrawn from the human subject a chemical agent such as heparin may be administered to the subject for purposes of inducing lymphocyte migration from the lymph system into the circulatory system.
    Type: Grant
    Filed: July 19, 1990
    Date of Patent: April 14, 1992
    Assignee: American Immuno Tech, Inc.
    Inventors: Alan A. Davidner, Henry V. Roohk, Max D. Lechtman
  • Method for extracorporeal blood shear treatment
    Patent number: 4950225
    Abstract: Disclosed is a multimodal method and apparatus for extracorporeally treating certain blood borne infections, such as the infection of T-lymphocytes with the Human Immunodeficiency Virus. The method and apparatus of the invention includes (a) hyperthermic, (b) mechanical shear inducing, and (c) irradiation treatment modalities. These three treatment modalities may be carried out separately, in any order, or simultaneously, in any combination. The irradiation treatment mode preferably includes methods and means for subjecting at least a fraction of the blood to ultraviolet and/or x-ray and/or laser radiation. Before the blood is withdrawn from the human subject a chemical agent such as heparin may be administered to the subject for purposes of inducing lymphocyte migration from the lymph system into the circulatory system.
    Type: Grant
    Filed: September 22, 1988
    Date of Patent: August 21, 1990
    Assignee: American Immuno Tech, Inc.
    Inventors: Alan A. Davidner, Henry V. Roohk, Max D. Lechtman